Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection
Public ClinicalTrials.gov record NCT01118663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Randomized, Controlled Study to Determine the Efficacy and Safety of a New Formulation of Acetylcysteine Injection
Study identification
- NCT ID
- NCT01118663
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cumberland Pharmaceuticals
- Industry
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Interventions
- Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free) Drug
- Acetadote Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- Oct 31, 2012
- Completion
- Apr 30, 2013
- Last update posted
- Aug 3, 2014
2010 – 2013
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Maricopa Medical Center | Phoenix | Arizona | 85008 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92350 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| UCSD Medical Center | San Diego | California | 92103 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| Denver Health and Hospital Authority | Denver | Colorado | 80204 | — |
| Hartford Hospital | Hartford | Connecticut | 06102 | — |
| LSU Health Sciences Center - Shreveport | Shreveport | Louisiana | 71130 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Spectrum Health Butterworth Hospital | Grand Rapids | Michigan | 44506 | — |
| East Carolina University Medical Center | Greenville | North Carolina | 27834 | — |
| Toledo Hospital | Toledo | Ohio | 43606 | — |
| Scott & White Medical Center | Temple | Texas | 76508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01118663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01118663 live on ClinicalTrials.gov.